Claim CME

Health Disparities

Buprenorphine Treatment Divide by Race/Ethnicity and Payment

Educational Objective
To understand the relationship between race, ethnicity and economic factors and buprenorphine treatment.

1 Credit CME

JAMA Psychiatry

September 1, 2019

Research Letter

Article Information and Disclosures

Pooja A. Lagisetty, MD, MSc^1,2,3;

Ryan Ross, BS⁴;

Amy Bohnert, PhD^2,3,5;

et al

Michael Clay, MD^1,6;

Donovan T. Maust, MD, MSc^2,3,5

Author Affiliations

¹Department of Medicine, University of Michigan, School of Medicine, Ann Arbor
²Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan
³Institute for Health Policy and Innovation, Ann Arbor, Michigan
⁴Department of Biostatistics, University of Michigan, School of Public Health, Ann Arbor
⁵Department of Psychiatry, University of Michigan, School of Medicine, Ann Arbor
⁶VA Ann Arbor Healthcare System, Ann Arbor, Michigan

Read article on JAMA Network

Read Article Claim CME

Claim CME

Buy This Activity

Article Information

Accepted for Publication: March 12, 2019.

Corresponding Author: Pooja Lagisetty, MD, MSc, NCRC B16-Floor 2, 2800 Plymouth Rd, Ann Arbor, MI 48109 (lagiset@med.umich.edu).

Published Online: May 8, 2019. doi:10.1001/jamapsychiatry.2019.0876

Author Contributions: Dr Lagisetty and Mr Ross had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Lagisetty.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Lagisetty, Ross, Maust.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Ross.

Administrative, technical, or material support: Lagisetty, Clay.

Supervision: Lagisetty, Maust.

Other - mentoring: Bohnert.

Conflict of Interest Disclosures: None reported.

References

Alexander MJ, Kiang MV, Barbieri M. Trends in black and white opioid mortality in the United States, 1979-2015. Epidemiology. 2018;29(5):707-715. doi:10.1097/EDE.0000000000000858 PubMed Google Scholar Crossref

Hansen H, Siegel C, Wanderling J, DiRocco D. Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. Drug Alcohol Depend. 2016;164:14-21. doi:10.1016/j.drugalcdep.2016.03.028 PubMed Google Scholar Crossref

Breen CT, Fiellin DA. Buprenorphine supply, access, and quality: where we have come and the path forward. J Law Med Ethics. 2018;46(2):272-278. doi:10.1177/1073110518782934 PubMed Google Scholar Crossref

Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. Results from the 2017 National Survey on Drug Use and Health: Detailed Tables. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.pdf. Published September 7, 2018. Accessed April 2, 2019.

Andrews CM, Grogan CM, Smith BT, et al. Medicaid benefits for addiction treatment expanded after implementation of the Affordable Care Act. Health Aff (Millwood). 2018;37(8):1216-1222. doi:10.1377/hlthaff.2018.0272 PubMed Google Scholar Crossref

Parran TV, Muller JZ, Chernyak E, et al. Access to and payment for office-based buprenorphine treatment in Ohio. Subst Abuse. 2017;11:1178221817699247.PubMed Google Scholar

Buprenorphine Treatment Divide by Race/Ethnicity and Payment

See More About

If you are not a JN Learning subscriber, you can either:

A subscription to JN Learning (CME from JAMA Network) provides:

Sign in to access

If you are not a JN Learning subscriber, you can either:

Sign in to customize your interests

With a personal account, you can:

Name Your Search

Sign in to save your search

With a personal account, you can:

Lookup An Activity

My Saved Searches

Sign in to customize your interests

With a personal account, you can:

Purchase access